BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20056733)

  • 1. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options.
    Holland AE
    Chron Respir Dis; 2010; 7(2):101-11. PubMed ID: 20056733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.
    Holland AE; Hill CJ; Conron M; Munro P; McDonald CF
    Thorax; 2008 Jun; 63(6):549-54. PubMed ID: 18245143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus.
    Forte S; Carlone S; Vaccaro F; Onorati P; Manfredi F; Serra P; Palange P
    J Rheumatol; 1999 Dec; 26(12):2591-4. PubMed ID: 10606367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
    Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
    Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical therapy for chronic obstructive pulmonary disease.
    Martinez FJ; Chang A
    Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases.
    Ferrazza AM; Martolini D; Valli G; Palange P
    Respiration; 2009; 77(1):3-17. PubMed ID: 19145106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function testing in interstitial lung diseases.
    Chetta A; Marangio E; Olivieri D
    Respiration; 2004; 71(3):209-13. PubMed ID: 15133338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease.
    Holland AE; Hill CJ; Glaspole I; Goh N; Dowman L; McDonald CF
    Respir Med; 2013 Jul; 107(7):1066-72. PubMed ID: 23669412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia.
    Troy LK; Young IH; Lau EM; Corte TJ
    Respirology; 2016 Aug; 21(6):1005-14. PubMed ID: 26416262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exercise testing in interstitial lung disease.
    Marciniuk DD; Gallagher CG
    Clin Chest Med; 1994 Jun; 15(2):287-303. PubMed ID: 8088094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease.
    Dodd JD; Barry SC; Gallagher CG
    Respir Physiol Neurobiol; 2006 Jun; 152(2):176-85. PubMed ID: 16169290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise performance and limiting factors in patients with chronic lung diseases.
    Kurihara N; Fujimoto S; Terakawa K; Ohta K; Hirata K; Nakaoka Y; Hiraga T; Nakano Y; Nakano N; Matsushita H
    Osaka City Med J; 1990 Nov; 36(2):129-39. PubMed ID: 2074970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.
    Huppmann P; Sczepanski B; Boensch M; Winterkamp S; Schönheit-Kenn U; Neurohr C; Behr J; Kenn K
    Eur Respir J; 2013 Aug; 42(2):444-53. PubMed ID: 23100507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation.
    Jastrzebski D; Gumola A; Gawlik R; Kozielski J
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():139-48. PubMed ID: 17072040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of expiratory muscle training in severe COPD patients.
    Mota S; Güell R; Barreiro E; Solanes I; Ramírez-Sarmiento A; Orozco-Levi M; Casan P; Gea J; Sanchis J
    Respir Med; 2007 Mar; 101(3):516-24. PubMed ID: 16942867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dyspnea in interstitial lung disease.
    Ryerson CJ; Collard HR; Pantilat SZ
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):69-75. PubMed ID: 20375900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current best practice in rehabilitation in interstitial lung disease.
    Nakazawa A; Cox NS; Holland AE
    Ther Adv Respir Dis; 2017 Feb; 11(2):115-128. PubMed ID: 28150539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airflow obstruction and exercise.
    Cooper CB
    Respir Med; 2009 Mar; 103(3):325-34. PubMed ID: 19071004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function tests.
    Behr J; Furst DE
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.